Cannabidiol improves metabolic dysfunction in middle-aged diabetic rats submitted to a chronic cerebral hypoperfusion.

[1]  A. Riffel,et al.  Age-related changes and effects of regular low-intensity exercise on gait, balance, and oxidative biomarkers in the spinal cord of Wistar rats , 2019, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[2]  E. Lo,et al.  Effects of aging, hypertension and diabetes on the mouse brain and heart vasculomes , 2019, Neurobiology of Disease.

[3]  I. Hirsch,et al.  Non‐insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions , 2019, Diabetic medicine : a journal of the British Diabetic Association.

[4]  M. Falasca,et al.  Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids. , 2019, Pharmacological research.

[5]  S. M. Sivakumar,et al.  Hepatoprotective Potential of Sargassum muticum against STZ-Induced Diabetic Liver Damage in Wistar Rats by Inhibiting Cytokines and the Apoptosis Pathway , 2019, Analytical cellular pathology.

[6]  B. Strooper,et al.  Diabetes and Alzheimer’s Disease: A Link not as Simple as it Seems , 2018, Neurochemical Research.

[7]  Muhammad A. Alsherbiny,et al.  Medicinal Cannabis—Potential Drug Interactions , 2018, Medicines.

[8]  F. Guimarães,et al.  Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats , 2018, Neurotoxicity Research.

[9]  H. Goyal,et al.  Cannabis in liver disorders: a friend or a foe? , 2018, European journal of gastroenterology & hepatology.

[10]  S. Benvenuti,et al.  New Methods for the Comprehensive Analysis of Bioactive Compounds in Cannabis sativa L. (hemp) , 2018, Molecules.

[11]  Soo Hyun Kwon,et al.  Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects , 2018, Clinical nutrition research.

[12]  Jared M. Campbell,et al.  Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis , 2018, Journal of Alzheimer's disease : JAD.

[13]  J. Kinney,et al.  Intermittent streptozotocin administration induces behavioral and pathological features relevant to Alzheimer's disease and vascular dementia , 2018, Neuropharmacology.

[14]  C. C. da Silva Franco,et al.  Stevia Nonsweetener Fraction Displays an Insulinotropic Effect Involving Neurotransmission in Pancreatic Islets , 2018, International journal of endocrinology.

[15]  F. Bermúdez-Silva,et al.  LH‐21 and abnormal cannabidiol improve β‐cell function in isolated human and mouse islets through GPR55‐dependent and ‐independent signalling , 2018, Diabetes, obesity & metabolism.

[16]  K. Becker,et al.  Absence of cannabinoid 1 receptor in beta cells protects against high-fat/high-sugar diet-induced beta cell dysfunction and inflammation in murine islets , 2018, Diabetologia.

[17]  H. Milani,et al.  Cognitive, neurohistological and mortality outcomes following the four-vessel occlusion/internal carotid artery model of chronic cerebral hypoperfusion: The impact of diabetes and aging , 2018, Behavioural Brain Research.

[18]  V. Kitrytė,et al.  Biorefining of industrial hemp (Cannabis sativa L.) threshing residues into cannabinoid and antioxidant fractions by supercritical carbon dioxide, pressurized liquid and enzyme-assisted extractions. , 2017, Food chemistry.

[19]  Yong Zhao,et al.  Bioactive spirans and other constituents from the leaves of Cannabis sativa f. sativa , 2017, Journal of Asian natural products research.

[20]  IfflandKerstin,et al.  An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies , 2017 .

[21]  F. Guimarães,et al.  Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia , 2017, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  Juan Zhou,et al.  Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes. , 2017, Clinical hemorheology and microcirculation.

[23]  Peter M. Jones,et al.  GPR55‐dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans , 2016, Diabetes, obesity & metabolism.

[24]  F. Guimarães,et al.  Cannabidiol, neuroprotection and neuropsychiatric disorders. , 2016, Pharmacological research.

[25]  P. Flatt,et al.  Metabolic effects of orally administered small-molecule agonists of GPR55 and GPR119 in multiple low-dose streptozotocin-induced diabetic and incretin-receptor-knockout mice , 2016, Diabetologia.

[26]  Jimmy D Bell,et al.  Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study , 2016, Diabetes Care.

[27]  G. Meneilly,et al.  Diabetes, Dementia and Hypoglycemia. , 2016, Canadian journal of diabetes.

[28]  A. Tabarin,et al.  The cannabinoid CB1 receptor and mTORC1 signalling pathways interact to modulate glucose homeostasis in mice , 2016, Disease Models & Mechanisms.

[29]  T. Ninomiya,et al.  Diabetes Mellitus and Dementia , 2014, Current Diabetes Reports.

[30]  I. Galve-Roperh,et al.  Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. , 2013, Progress in lipid research.

[31]  H. Milani,et al.  Neurohistological and behavioral changes following the four-vessel occlusion/internal carotid artery model of chronic cerebral hypoperfusion: Comparison between normotensive and spontaneously hypertensive rats , 2013, Behavioural Brain Research.

[32]  P. Sengupta.  The Laboratory Rat: Relating Its Age With Human's , 2013, International journal of preventive medicine.

[33]  A. Merzouki,et al.  Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency. , 2013, Nutricion hospitalaria.

[34]  P. Bhutada,et al.  Agmatine, an endogenous ligand of imidazoline receptor protects against memory impairment and biochemical alterations in streptozotocin-induced diabetic rats , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[35]  P. Pacher,et al.  The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. , 2012, The American journal of pathology.

[36]  N. Grigoriadis,et al.  Cannabidiol improves brain and liver function in a fulminant hepatic failure‐induced model of hepatic encephalopathy in mice , 2011, British journal of pharmacology.

[37]  A. Veves,et al.  Cannabidiol Attenuates Cardiac Dysfunction , Oxidative Stress , Fibrosis , and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy , 2017 .

[38]  B. Costa,et al.  Beneficial effects of a Cannabis sativa extract treatment on diabetes‐induced neuropathy and oxidative stress , 2009, Phytotherapy research : PTR.

[39]  P. Scheltens,et al.  Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.

[40]  M. Zeira,et al.  Cannabidiol lowers incidence of diabetes in non-obese diabetic mice , 2006, Autoimmunity.

[41]  Ronald C Petersen,et al.  Increased risk of type 2 diabetes in Alzheimer disease. , 2004, Diabetes.

[42]  Wei He,et al.  Effects of scutellarin on liver function after brain ischemia/reperfusion in rats. , 2003, Acta pharmacologica Sinica.

[43]  Claudio Cobelli,et al.  Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. , 2003, Diabetes.

[44]  R. Bazotte,et al.  Evaluation of the population of NADPH-diaphorase-stained and myosin-V myenteric neurons in the ileum of chronically streptozotocin-diabetic rats treated with ascorbic acid , 2003, Autonomic Neuroscience.

[45]  K. Rockwood,et al.  Diabetes mellitus and the Risk of Dementia, Alzheimer’s Disease and Vascular Cognitive Impairment in the Canadian Study of Health and Aging , 2002, Dementia and Geriatric Cognitive Disorders.

[46]  P. Ferranti,et al.  Production, digestibility and allergenicity of hemp (Cannabis sativa L.) protein isolates. , 2019, Food research international.

[47]  F. Azam,et al.  Is Cannabidiol a Promising Substance for New Drug Development? A Review of its Potential Therapeutic Applications. , 2018, Critical Reviews in Eukaryotic Gene Expression.

[48]  N. Andreollo,et al.  Rat's age versus human's age: what is the relationship? , 2012, Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery.

[49]  F. Piscitelli,et al.  Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. , 2011, Handbook of experimental pharmacology.